<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>Genome folding in evolution and disease</title>
  <meta name="description" content="A draft PhD thesis on genome folding in evoultion and disease.">
  <meta name="generator" content="bookdown 0.6.1 and GitBook 2.6.7">

  <meta property="og:title" content="Genome folding in evolution and disease" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://ibn-salem.github.io/thesis/" />
  
  <meta property="og:description" content="A draft PhD thesis on genome folding in evoultion and disease." />
  <meta name="github-repo" content="ibn-salem/thesis" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Genome folding in evolution and disease" />
  
  <meta name="twitter:description" content="A draft PhD thesis on genome folding in evoultion and disease." />
  

<meta name="author" content="Jonas Ibn-Salem">


<meta name="date" content="2018-02-21">

  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  
<link rel="prev" href="4-3-results-2.html">
<link rel="next" href="5-loop.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">Thesis</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="1" data-path="1-intro.html"><a href="1-intro.html"><i class="fa fa-check"></i><b>1</b> Introduction</a><ul>
<li class="chapter" data-level="1.1" data-path="1-1-regulation-of-expression.html"><a href="1-1-regulation-of-expression.html"><i class="fa fa-check"></i><b>1.1</b> Regulation of gene expression</a></li>
<li class="chapter" data-level="1.2" data-path="1-2-distal-regulation-by-enhancers.html"><a href="1-2-distal-regulation-by-enhancers.html"><i class="fa fa-check"></i><b>1.2</b> Distal regulation by enhancers</a></li>
<li class="chapter" data-level="1.3" data-path="1-3-methods-to-probe-the-3d-chromatin-architecture.html"><a href="1-3-methods-to-probe-the-3d-chromatin-architecture.html"><i class="fa fa-check"></i><b>1.3</b> Methods to probe the 3D chromatin architecture</a><ul>
<li class="chapter" data-level="1.3.1" data-path="1-3-methods-to-probe-the-3d-chromatin-architecture.html"><a href="1-3-methods-to-probe-the-3d-chromatin-architecture.html#microscopy-based-techniques-to-visualize-the-genome-in-3d"><i class="fa fa-check"></i><b>1.3.1</b> Microscopy-based techniques to visualize the genome in 3D</a></li>
<li class="chapter" data-level="1.3.2" data-path="1-3-methods-to-probe-the-3d-chromatin-architecture.html"><a href="1-3-methods-to-probe-the-3d-chromatin-architecture.html#proximity-ligation"><i class="fa fa-check"></i><b>1.3.2</b> Proximity-ligation based method to quantify chromatin interactions</a></li>
</ul></li>
<li class="chapter" data-level="1.4" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html"><i class="fa fa-check"></i><b>1.4</b> Hierarchy of chromatin 3D structure</a><ul>
<li class="chapter" data-level="1.4.1" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#chromosomal-territories-and-inter-chromosomal-contacts"><i class="fa fa-check"></i><b>1.4.1</b> Chromosomal territories and inter-chromosomal contacts</a></li>
<li class="chapter" data-level="1.4.2" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#ab-compartments"><i class="fa fa-check"></i><b>1.4.2</b> A/B compartments</a></li>
<li class="chapter" data-level="1.4.3" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#topologically-associating-domains-tads"><i class="fa fa-check"></i><b>1.4.3</b> Topologically associating domains (TADs)</a></li>
<li class="chapter" data-level="1.4.4" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#hierarchy-of-domain-like-structures-across-genomic-length-scales"><i class="fa fa-check"></i><b>1.4.4</b> Hierarchy of domain-like structures across genomic-length scales</a></li>
<li class="chapter" data-level="1.4.5" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#chromatin-looping-interactions"><i class="fa fa-check"></i><b>1.4.5</b> Chromatin looping interactions</a></li>
<li class="chapter" data-level="1.4.6" data-path="1-4-hierarchy-of-chromatin-3d-structure.html"><a href="1-4-hierarchy-of-chromatin-3d-structure.html#loop-mechanism"><i class="fa fa-check"></i><b>1.4.6</b> TAD and loop formation by architectural proteins</a></li>
</ul></li>
<li class="chapter" data-level="1.5" data-path="1-5-dynamics-of-chromatin-structure.html"><a href="1-5-dynamics-of-chromatin-structure.html"><i class="fa fa-check"></i><b>1.5</b> Dynamics of chromatin structure</a><ul>
<li class="chapter" data-level="1.5.1" data-path="1-5-dynamics-of-chromatin-structure.html"><a href="1-5-dynamics-of-chromatin-structure.html#dynamics-across-cell-cycle"><i class="fa fa-check"></i><b>1.5.1</b> Dynamics across cell cycle</a></li>
<li class="chapter" data-level="1.5.2" data-path="1-5-dynamics-of-chromatin-structure.html"><a href="1-5-dynamics-of-chromatin-structure.html#dynamics-across-cell-types-and-differntiation"><i class="fa fa-check"></i><b>1.5.2</b> Dynamics across cell types and differntiation</a></li>
</ul></li>
<li class="chapter" data-level="1.6" data-path="1-6-evolution-of-chromatin-organization.html"><a href="1-6-evolution-of-chromatin-organization.html"><i class="fa fa-check"></i><b>1.6</b> Evolution of chromatin organization</a></li>
<li class="chapter" data-level="1.7" data-path="1-7-disruption-of-chromatin-architecture-in-disease.html"><a href="1-7-disruption-of-chromatin-architecture-in-disease.html"><i class="fa fa-check"></i><b>1.7</b> Disruption of chromatin architecture in disease</a></li>
<li class="chapter" data-level="1.8" data-path="1-8-aims-of-this-thesis.html"><a href="1-8-aims-of-this-thesis.html"><i class="fa fa-check"></i><b>1.8</b> Aims of this thesis</a></li>
<li class="chapter" data-level="1.9" data-path="1-9-structure-of-this-thesis.html"><a href="1-9-structure-of-this-thesis.html"><i class="fa fa-check"></i><b>1.9</b> Structure of this thesis</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="2-paralog-regulation.html"><a href="2-paralog-regulation.html"><i class="fa fa-check"></i><b>2</b> Paralog genes in the 3D genome architecture</a><ul>
<li class="chapter" data-level="" data-path="2-paralog-regulation.html"><a href="2-paralog-regulation.html#preamble"><i class="fa fa-check"></i>Preamble</a></li>
<li class="chapter" data-level="" data-path="2-paralog-regulation.html"><a href="2-paralog-regulation.html#abstract-1"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="2.1" data-path="2-1-introduction.html"><a href="2-1-introduction.html"><i class="fa fa-check"></i><b>2.1</b> Introduction</a></li>
<li class="chapter" data-level="2.2" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html"><i class="fa fa-check"></i><b>2.2</b> Materials and methods</a><ul>
<li class="chapter" data-level="2.2.1" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#selection-of-pairs-of-paralog-genes"><i class="fa fa-check"></i><b>2.2.1</b> Selection of pairs of paralog genes</a></li>
<li class="chapter" data-level="2.2.2" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#enhancers-to-gene-association"><i class="fa fa-check"></i><b>2.2.2</b> Enhancers to gene association</a></li>
<li class="chapter" data-level="2.2.3" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#topological-associating-domains"><i class="fa fa-check"></i><b>2.2.3</b> Topological associating domains</a></li>
<li class="chapter" data-level="2.2.4" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#hi-c-interaction-maps"><i class="fa fa-check"></i><b>2.2.4</b> Hi-C interaction maps</a></li>
<li class="chapter" data-level="2.2.5" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#randomization"><i class="fa fa-check"></i><b>2.2.5</b> Randomization</a></li>
<li class="chapter" data-level="2.2.6" data-path="2-2-sec-paralog-methods.html"><a href="2-2-sec-paralog-methods.html#statistical-tests"><i class="fa fa-check"></i><b>2.2.6</b> Statistical tests</a></li>
</ul></li>
<li class="chapter" data-level="2.3" data-path="2-3-results.html"><a href="2-3-results.html"><i class="fa fa-check"></i><b>2.3</b> Results</a><ul>
<li class="chapter" data-level="2.3.1" data-path="2-3-results.html"><a href="2-3-results.html#distribution-of-paralog-genes-in-the-human-genome"><i class="fa fa-check"></i><b>2.3.1</b> Distribution of paralog genes in the human genome</a></li>
<li class="chapter" data-level="2.3.2" data-path="2-3-results.html"><a href="2-3-results.html#co-expression-of-paralog-gene-pairs-across-tissues"><i class="fa fa-check"></i><b>2.3.2</b> Co-expression of paralog gene pairs across tissues</a></li>
<li class="chapter" data-level="2.3.3" data-path="2-3-results.html"><a href="2-3-results.html#paralog-genes-share-enhancers"><i class="fa fa-check"></i><b>2.3.3</b> Paralog genes share enhancers</a></li>
<li class="chapter" data-level="2.3.4" data-path="2-3-results.html"><a href="2-3-results.html#co-localization-of-paralogs-in-tads"><i class="fa fa-check"></i><b>2.3.4</b> Co-localization of paralogs in TADs</a></li>
<li class="chapter" data-level="2.3.5" data-path="2-3-results.html"><a href="2-3-results.html#distal-paralog-pairs-are-enriched-for-long-range-chromatin-contacts"><i class="fa fa-check"></i><b>2.3.5</b> Distal paralog pairs are enriched for long-range chromatin contacts</a></li>
<li class="chapter" data-level="2.3.6" data-path="2-3-results.html"><a href="2-3-results.html#close-paralogs-have-fewer-contacts-than-expected"><i class="fa fa-check"></i><b>2.3.6</b> Close paralogs have fewer contacts than expected</a></li>
<li class="chapter" data-level="2.3.7" data-path="2-3-results.html"><a href="2-3-results.html#paralogs-in-mouse-and-dog-genome"><i class="fa fa-check"></i><b>2.3.7</b> Paralogs in mouse and dog genome</a></li>
<li class="chapter" data-level="2.3.8" data-path="2-3-results.html"><a href="2-3-results.html#orthologs-of-human-paralogs-show-conserved-co-localization"><i class="fa fa-check"></i><b>2.3.8</b> Orthologs of human paralogs show conserved co-localization</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="2-4-discussions.html"><a href="2-4-discussions.html"><i class="fa fa-check"></i><b>2.4</b> Discussions</a></li>
<li class="chapter" data-level="2.5" data-path="2-5-conclusion.html"><a href="2-5-conclusion.html"><i class="fa fa-check"></i><b>2.5</b> Conclusion</a></li>
<li class="chapter" data-level="2.6" data-path="2-6-acknowledgements.html"><a href="2-6-acknowledgements.html"><i class="fa fa-check"></i><b>2.6</b> Acknowledgements</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="3-TAD-evolution.html"><a href="3-TAD-evolution.html"><i class="fa fa-check"></i><b>3</b> Stability of TADs in evolution</a><ul>
<li class="chapter" data-level="" data-path="3-TAD-evolution.html"><a href="3-TAD-evolution.html#preamble-1"><i class="fa fa-check"></i>Preamble</a></li>
<li class="chapter" data-level="" data-path="3-TAD-evolution.html"><a href="3-TAD-evolution.html#abstract-2"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="" data-path="3-TAD-evolution.html"><a href="3-TAD-evolution.html#keywords"><i class="fa fa-check"></i>Keywords</a></li>
<li class="chapter" data-level="3.1" data-path="3-1-introduction-1.html"><a href="3-1-introduction-1.html"><i class="fa fa-check"></i><b>3.1</b> Introduction</a></li>
<li class="chapter" data-level="3.2" data-path="3-2-results-1.html"><a href="3-2-results-1.html"><i class="fa fa-check"></i><b>3.2</b> Results</a><ul>
<li class="chapter" data-level="3.2.1" data-path="3-2-results-1.html"><a href="3-2-results-1.html#identification-of-evolutionary-rearrangement-breakpoints-from-whole-genome-alignments"><i class="fa fa-check"></i><b>3.2.1</b> Identification of evolutionary rearrangement breakpoints from whole-genome alignments</a></li>
<li class="chapter" data-level="3.2.2" data-path="3-2-results-1.html"><a href="3-2-results-1.html#rearrangement-breakpoints-are-enriched-at-tad-boundaries"><i class="fa fa-check"></i><b>3.2.2</b> Rearrangement breakpoints are enriched at TAD boundaries</a></li>
<li class="chapter" data-level="3.2.3" data-path="3-2-results-1.html"><a href="3-2-results-1.html#clusters-of-conserved-non-coding-elements-are-depleted-for-rearrangement-breakpoints"><i class="fa fa-check"></i><b>3.2.3</b> Clusters of conserved non-coding elements are depleted for rearrangement breakpoints</a></li>
<li class="chapter" data-level="3.2.4" data-path="3-2-results-1.html"><a href="3-2-results-1.html#rearranged-tads-are-associated-with-divergent-gene-expression-between-species"><i class="fa fa-check"></i><b>3.2.4</b> Rearranged TADs are associated with divergent gene expression between species</a></li>
</ul></li>
<li class="chapter" data-level="3.3" data-path="3-3-discussion.html"><a href="3-3-discussion.html"><i class="fa fa-check"></i><b>3.3</b> Discussion</a></li>
<li class="chapter" data-level="3.4" data-path="3-4-conclusion-1.html"><a href="3-4-conclusion-1.html"><i class="fa fa-check"></i><b>3.4</b> Conclusion</a></li>
<li class="chapter" data-level="3.5" data-path="3-5-methods.html"><a href="3-5-methods.html"><i class="fa fa-check"></i><b>3.5</b> Methods</a><ul>
<li class="chapter" data-level="3.5.1" data-path="3-5-methods.html"><a href="3-5-methods.html#rearrangement-breakpoints-from-whole-genome-alignments"><i class="fa fa-check"></i><b>3.5.1</b> Rearrangement breakpoints from whole-genome alignments</a></li>
<li class="chapter" data-level="3.5.2" data-path="3-5-methods.html"><a href="3-5-methods.html#topologically-associating-domains-and-contact-domains"><i class="fa fa-check"></i><b>3.5.2</b> Topologically associating domains and contact domains</a></li>
<li class="chapter" data-level="3.5.3" data-path="3-5-methods.html"><a href="3-5-methods.html#breakpoint-distributions-at-tads"><i class="fa fa-check"></i><b>3.5.3</b> Breakpoint distributions at TADs</a></li>
<li class="chapter" data-level="3.5.4" data-path="3-5-methods.html"><a href="3-5-methods.html#quantification-of-breakpoint-enrichment"><i class="fa fa-check"></i><b>3.5.4</b> Quantification of breakpoint enrichment</a></li>
<li class="chapter" data-level="3.5.5" data-path="3-5-methods.html"><a href="3-5-methods.html#expression-data-for-mouse-and-human-orthologs"><i class="fa fa-check"></i><b>3.5.5</b> Expression data for mouse and human orthologs</a></li>
<li class="chapter" data-level="3.5.6" data-path="3-5-methods.html"><a href="3-5-methods.html#classification-of-tads-and-genes-according-to-rearrangements-and-grbs"><i class="fa fa-check"></i><b>3.5.6</b> Classification of TADs and genes according to rearrangements and GRBs</a></li>
<li class="chapter" data-level="3.5.7" data-path="3-5-methods.html"><a href="3-5-methods.html#source-code-and-implementation-details"><i class="fa fa-check"></i><b>3.5.7</b> Source code and implementation details</a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="3-6-declarations.html"><a href="3-6-declarations.html"><i class="fa fa-check"></i><b>3.6</b> Declarations</a><ul>
<li class="chapter" data-level="3.6.1" data-path="3-6-declarations.html"><a href="3-6-declarations.html#ethics-approval-and-consent-to-participate"><i class="fa fa-check"></i><b>3.6.1</b> Ethics approval and consent to participate</a></li>
<li class="chapter" data-level="3.6.2" data-path="3-6-declarations.html"><a href="3-6-declarations.html#consent-for-publication"><i class="fa fa-check"></i><b>3.6.2</b> Consent for publication</a></li>
<li class="chapter" data-level="3.6.3" data-path="3-6-declarations.html"><a href="3-6-declarations.html#availability-of-data-and-material"><i class="fa fa-check"></i><b>3.6.3</b> Availability of data and material</a></li>
<li class="chapter" data-level="3.6.4" data-path="3-6-declarations.html"><a href="3-6-declarations.html#competing-interests"><i class="fa fa-check"></i><b>3.6.4</b> Competing interests</a></li>
<li class="chapter" data-level="3.6.5" data-path="3-6-declarations.html"><a href="3-6-declarations.html#funding"><i class="fa fa-check"></i><b>3.6.5</b> Funding</a></li>
<li class="chapter" data-level="3.6.6" data-path="3-6-declarations.html"><a href="3-6-declarations.html#authors-contributions"><i class="fa fa-check"></i><b>3.6.6</b> Authors‘ contributions</a></li>
<li class="chapter" data-level="3.6.7" data-path="3-6-declarations.html"><a href="3-6-declarations.html#acknowledgments"><i class="fa fa-check"></i><b>3.6.7</b> Acknowledgments</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="4-position-effect.html"><a href="4-position-effect.html"><i class="fa fa-check"></i><b>4</b> Position effects of rearrangements in disease genomes</a><ul>
<li class="chapter" data-level="" data-path="4-position-effect.html"><a href="4-position-effect.html#preamble-2"><i class="fa fa-check"></i>Preamble</a></li>
<li class="chapter" data-level="" data-path="4-position-effect.html"><a href="4-position-effect.html#abstract-3"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="4.1" data-path="4-1-introduction-2.html"><a href="4-1-introduction-2.html"><i class="fa fa-check"></i><b>4.1</b> Introduction</a></li>
<li class="chapter" data-level="4.2" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html"><i class="fa fa-check"></i><b>4.2</b> Materials and Methods</a><ul>
<li class="chapter" data-level="4.2.1" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#selection-of-subjects-with-apparently-balanced-chromosome-abnormalities"><i class="fa fa-check"></i><b>4.2.1</b> Selection of subjects with apparently balanced chromosome abnormalities</a></li>
<li class="chapter" data-level="4.2.2" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#clinical-descriptions-of-dgap-cases"><i class="fa fa-check"></i><b>4.2.2</b> Clinical descriptions of DGAP cases</a></li>
<li class="chapter" data-level="4.2.3" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#analysis-of-genes-bordering-the-rearrangement-breakpoints"><i class="fa fa-check"></i><b>4.2.3</b> Analysis of genes bordering the rearrangement breakpoints</a></li>
<li class="chapter" data-level="4.2.4" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#assessment-of-disrupted-functional-elements-and-chromatin-interactions-bordering-rearrangement-breakpoints"><i class="fa fa-check"></i><b>4.2.4</b> Assessment of disrupted functional elements and chromatin interactions bordering rearrangement breakpoints</a></li>
<li class="chapter" data-level="4.2.5" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#ontological-analysis-of-genes-neighboring-breakpoints"><i class="fa fa-check"></i><b>4.2.5</b> Ontological analysis of genes neighboring breakpoints</a></li>
<li class="chapter" data-level="4.2.6" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#quantitative-real-time-pcr"><i class="fa fa-check"></i><b>4.2.6</b> Quantitative real-time PCR</a></li>
<li class="chapter" data-level="4.2.7" data-path="4-2-materials-and-methods.html"><a href="4-2-materials-and-methods.html#assessment-of-dgap-breakpoints-overlapping-with-non-coding-structural-variants-in-public-databases"><i class="fa fa-check"></i><b>4.2.7</b> Assessment of DGAP breakpoints overlapping with non-coding structural variants in public databases</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="4-3-results-2.html"><a href="4-3-results-2.html"><i class="fa fa-check"></i><b>4.3</b> Results</a><ul>
<li class="chapter" data-level="4.3.1" data-path="4-3-results-2.html"><a href="4-3-results-2.html#genomic-characterization-of-non-coding-breakpoints"><i class="fa fa-check"></i><b>4.3.1</b> Genomic characterization of non-coding breakpoints</a></li>
<li class="chapter" data-level="4.3.2" data-path="4-3-results-2.html"><a href="4-3-results-2.html#identification-of-genes-with-potential-position-effects"><i class="fa fa-check"></i><b>4.3.2</b> Identification of genes with potential position effects</a></li>
<li class="chapter" data-level="4.3.3" data-path="4-3-results-2.html"><a href="4-3-results-2.html#identification-of-subjects-with-shared-non-coding-chromosome-alterations-and-phenotypes"><i class="fa fa-check"></i><b>4.3.3</b> Identification of subjects with shared non-coding chromosome alterations and phenotypes</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="4-4-discussion-1.html"><a href="4-4-discussion-1.html"><i class="fa fa-check"></i><b>4.4</b> Discussion</a><ul>
<li class="chapter" data-level="" data-path="4-4-discussion-1.html"><a href="4-4-discussion-1.html#acknowledgements-1"><i class="fa fa-check"></i>Acknowledgements</a></li>
<li class="chapter" data-level="4.4.1" data-path="4-4-discussion-1.html"><a href="4-4-discussion-1.html#web-resources"><i class="fa fa-check"></i><b>4.4.1</b> Web Resources</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="5-loop.html"><a href="5-loop.html"><i class="fa fa-check"></i><b>5</b> Prediction of chromatin looping interactions</a><ul>
<li class="chapter" data-level="" data-path="5-loop.html"><a href="5-loop.html#preamble-3"><i class="fa fa-check"></i>Preamble</a></li>
<li class="chapter" data-level="" data-path="5-loop.html"><a href="5-loop.html#abstract-4"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="" data-path="5-loop.html"><a href="5-loop.html#keywords-1"><i class="fa fa-check"></i>Keywords</a></li>
<li class="chapter" data-level="5.1" data-path="5-1-introduction-3.html"><a href="5-1-introduction-3.html"><i class="fa fa-check"></i><b>5.1</b> Introduction</a></li>
<li class="chapter" data-level="5.2" data-path="5-2-results-3.html"><a href="5-2-results-3.html"><i class="fa fa-check"></i><b>5.2</b> Results</a><ul>
<li class="chapter" data-level="5.2.1" data-path="5-2-results-3.html"><a href="5-2-results-3.html#ctcf-motif-pairs-as-candidate-chromatin-loop-anchors"><i class="fa fa-check"></i><b>5.2.1</b> CTCF motif pairs as candidate chromatin loop anchors</a></li>
<li class="chapter" data-level="5.2.2" data-path="5-2-results-3.html"><a href="5-2-results-3.html#similarity-of-chip-seq-signals-at-looping-ctcf-motifs"><i class="fa fa-check"></i><b>5.2.2</b> Similarity of ChIP-seq signals at looping CTCF motifs</a></li>
<li class="chapter" data-level="5.2.3" data-path="5-2-results-3.html"><a href="5-2-results-3.html#genomic-sequence-features-of-ctcf-motif-pairs-are-associated-with-looping"><i class="fa fa-check"></i><b>5.2.3</b> Genomic sequence features of CTCF motif pairs are associated with looping</a></li>
<li class="chapter" data-level="5.2.4" data-path="5-2-results-3.html"><a href="5-2-results-3.html#chromatin-loop-prediction-using-7c"><i class="fa fa-check"></i><b>5.2.4</b> Chromatin loop prediction using 7C</a></li>
<li class="chapter" data-level="5.2.5" data-path="5-2-results-3.html"><a href="5-2-results-3.html#prediction-performance-evaluation"><i class="fa fa-check"></i><b>5.2.5</b> Prediction performance evaluation</a></li>
<li class="chapter" data-level="5.2.6" data-path="5-2-results-3.html"><a href="5-2-results-3.html#prediction-performance-of-7c-with-sequence-features-and-single-tf-chip-seq-data-sets"><i class="fa fa-check"></i><b>5.2.6</b> Prediction performance of 7C with sequence features and single TF ChIP-seq data sets</a></li>
<li class="chapter" data-level="5.2.7" data-path="5-2-results-3.html"><a href="5-2-results-3.html#comparison-of-transcription-factors-by-prediction-performance"><i class="fa fa-check"></i><b>5.2.7</b> Comparison of transcription factors by prediction performance</a></li>
<li class="chapter" data-level="5.2.8" data-path="5-2-results-3.html"><a href="5-2-results-3.html#prediction-performance-in-other-cell-types-and-for-different-tfs"><i class="fa fa-check"></i><b>5.2.8</b> Prediction performance in other cell types and for different TFs</a></li>
<li class="chapter" data-level="5.2.9" data-path="5-2-results-3.html"><a href="5-2-results-3.html#the-high-resolution-of-chip-nexus-improves-prediction-performance"><i class="fa fa-check"></i><b>5.2.9</b> The high resolution of ChIP-nexus improves prediction performance</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="5-3-discussion-2.html"><a href="5-3-discussion-2.html"><i class="fa fa-check"></i><b>5.3</b> Discussion</a></li>
<li class="chapter" data-level="5.4" data-path="5-4-conclusion-2.html"><a href="5-4-conclusion-2.html"><i class="fa fa-check"></i><b>5.4</b> Conclusion</a></li>
<li class="chapter" data-level="5.5" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html"><i class="fa fa-check"></i><b>5.5</b> Methods</a><ul>
<li class="chapter" data-level="5.5.1" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#ctcf-motifs-in-the-human-genome"><i class="fa fa-check"></i><b>5.5.1</b> CTCF motifs in the human genome</a></li>
<li class="chapter" data-level="5.5.2" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#loop-interaction-data-for-training-and-validation"><i class="fa fa-check"></i><b>5.5.2</b> Loop interaction data for training and validation</a></li>
<li class="chapter" data-level="5.5.3" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#chip-seq-datasets-in-gm12878-cells"><i class="fa fa-check"></i><b>5.5.3</b> ChIP-seq datasets in GM12878 cells</a></li>
<li class="chapter" data-level="5.5.4" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#chip-seq-data-types"><i class="fa fa-check"></i><b>5.5.4</b> ChIP-seq data types</a></li>
<li class="chapter" data-level="5.5.5" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#chip-nexus-data-processing-for-rad21-and-scm3"><i class="fa fa-check"></i><b>5.5.5</b> ChIP-nexus data processing for RAD21 and SCM3</a></li>
<li class="chapter" data-level="5.5.6" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#similarity-of-chip-seq-profiles-as-correlation-of-coverage-around-motifs"><i class="fa fa-check"></i><b>5.5.6</b> Similarity of ChIP-seq profiles as correlation of coverage around motifs</a></li>
<li class="chapter" data-level="5.5.7" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#genomic-sequence-features-of-chromatin-loops"><i class="fa fa-check"></i><b>5.5.7</b> Genomic sequence features of chromatin loops</a></li>
<li class="chapter" data-level="5.5.8" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#chromatin-loop-prediction-model"><i class="fa fa-check"></i><b>5.5.8</b> Chromatin Loop prediction model</a></li>
<li class="chapter" data-level="5.5.9" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#training-and-validation-of-prediction-model"><i class="fa fa-check"></i><b>5.5.9</b> Training and validation of prediction model</a></li>
<li class="chapter" data-level="5.5.10" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#analysis-of-prediction-performance"><i class="fa fa-check"></i><b>5.5.10</b> Analysis of prediction performance</a></li>
<li class="chapter" data-level="5.5.11" data-path="5-5-methods-1.html"><a href="5-5-methods-1.html#implementation-of-7c-and-compatibility-to-other-tools"><i class="fa fa-check"></i><b>5.5.11</b> Implementation of 7C and compatibility to other tools</a></li>
</ul></li>
<li class="chapter" data-level="5.6" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html"><i class="fa fa-check"></i><b>5.6</b> Declarations</a><ul>
<li class="chapter" data-level="5.6.1" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#ethics-approval-and-consent-to-participate-1"><i class="fa fa-check"></i><b>5.6.1</b> Ethics approval and consent to participate</a></li>
<li class="chapter" data-level="5.6.2" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#consent-for-publication-1"><i class="fa fa-check"></i><b>5.6.2</b> Consent for publication</a></li>
<li class="chapter" data-level="5.6.3" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#availability-of-data-and-material-1"><i class="fa fa-check"></i><b>5.6.3</b> Availability of data and material</a></li>
<li class="chapter" data-level="5.6.4" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#competing-interests-1"><i class="fa fa-check"></i><b>5.6.4</b> Competing interests</a></li>
<li class="chapter" data-level="5.6.5" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#funding-1"><i class="fa fa-check"></i><b>5.6.5</b> Funding</a></li>
<li class="chapter" data-level="5.6.6" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#authors-contributions-1"><i class="fa fa-check"></i><b>5.6.6</b> Authors‘ contributions</a></li>
<li class="chapter" data-level="5.6.7" data-path="5-6-declarations-1.html"><a href="5-6-declarations-1.html#acknowledgments-1"><i class="fa fa-check"></i><b>5.6.7</b> Acknowledgments</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="6-thesis-discussion.html"><a href="6-thesis-discussion.html"><i class="fa fa-check"></i><b>6</b> Discussion</a><ul>
<li class="chapter" data-level="6.1" data-path="6-1-co-regulation-of-functionally-related-genes-in-tads.html"><a href="6-1-co-regulation-of-functionally-related-genes-in-tads.html"><i class="fa fa-check"></i><b>6.1</b> Co-regulation of functionally related genes in TADs</a></li>
<li class="chapter" data-level="6.2" data-path="6-2-evolution-by-gene-duplications-and-altered-regulatory-environments.html"><a href="6-2-evolution-by-gene-duplications-and-altered-regulatory-environments.html"><i class="fa fa-check"></i><b>6.2</b> Evolution by gene duplications and altered regulatory environments</a></li>
<li class="chapter" data-level="6.3" data-path="6-3-tads-are-stable-across-large-evolutionary-time-scales.html"><a href="6-3-tads-are-stable-across-large-evolutionary-time-scales.html"><i class="fa fa-check"></i><b>6.3</b> TADs are stable across large evolutionary time-scales</a></li>
<li class="chapter" data-level="6.4" data-path="6-4-TAD-disease.html"><a href="6-4-TAD-disease.html"><i class="fa fa-check"></i><b>6.4</b> Gene expression changes by altered TADs in disease</a></li>
<li class="chapter" data-level="6.5" data-path="6-5-genome-folding-data-can-explain-the-pathomechanism-of-structural-variants.html"><a href="6-5-genome-folding-data-can-explain-the-pathomechanism-of-structural-variants.html"><i class="fa fa-check"></i><b>6.5</b> Genome folding data can explain the pathomechanism of structural variants</a></li>
<li class="chapter" data-level="6.6" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html"><i class="fa fa-check"></i><b>6.6</b> Towards studying condition specific genome folding</a><ul>
<li class="chapter" data-level="6.6.1" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html#interpretation-of-genetic-variants-by-interacting-genes"><i class="fa fa-check"></i><b>6.6.1</b> Interpretation of genetic variants by interacting genes</a></li>
<li class="chapter" data-level="6.6.2" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html#cell-type-specific-regulatory-interactions-between-enhancers-and-genes"><i class="fa fa-check"></i><b>6.6.2</b> Cell type-specific regulatory interactions between enhancers and genes</a></li>
<li class="chapter" data-level="6.6.3" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html#variability-of-long-range-interactions-across-individuals"><i class="fa fa-check"></i><b>6.6.3</b> Variability of long-range interactions across individuals</a></li>
<li class="chapter" data-level="6.6.4" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html#genome-folding-in-single-cells"><i class="fa fa-check"></i><b>6.6.4</b> Genome folding in single cells</a></li>
<li class="chapter" data-level="6.6.5" data-path="6-6-towards-studying-condition-specific-genome-folding.html"><a href="6-6-towards-studying-condition-specific-genome-folding.html#constantly-improving-targeted-experimental-methods."><i class="fa fa-check"></i><b>6.6.5</b> Constantly improving targeted experimental methods.</a></li>
</ul></li>
<li class="chapter" data-level="6.7" data-path="6-7-architectural-proteins-mediate-chromatin-looping.html"><a href="6-7-architectural-proteins-mediate-chromatin-looping.html"><i class="fa fa-check"></i><b>6.7</b> Architectural proteins mediate chromatin looping</a></li>
<li class="chapter" data-level="6.8" data-path="6-8-further-directions.html"><a href="6-8-further-directions.html"><i class="fa fa-check"></i><b>6.8</b> Further directions</a><ul>
<li class="chapter" data-level="6.8.1" data-path="6-8-further-directions.html"><a href="6-8-further-directions.html#limitation-of-the-analysis"><i class="fa fa-check"></i><b>6.8.1</b> Limitation of the analysis</a></li>
</ul></li>
<li class="chapter" data-level="6.9" data-path="6-9-conclusions.html"><a href="6-9-conclusions.html"><i class="fa fa-check"></i><b>6.9</b> Conclusions</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="appendix"><span><b>Appendix</b></span></li>
<li class="chapter" data-level="A" data-path="A-sup-paralog-regulation.html"><a href="A-sup-paralog-regulation.html"><i class="fa fa-check"></i><b>A</b> Supporting Information: Co-regulation of paralog genes</a></li>
<li class="chapter" data-level="B" data-path="B-sup-tad-evolution.html"><a href="B-sup-tad-evolution.html"><i class="fa fa-check"></i><b>B</b> Supplementary Data: Stability of TADs in evolution</a><ul>
<li class="chapter" data-level="B.1" data-path="B-1-TadEvoSupTab.html"><a href="B-1-TadEvoSupTab.html"><i class="fa fa-check"></i><b>B.1</b> Supplementary Tables</a></li>
<li class="chapter" data-level="B.2" data-path="B-2-supplementary-figures.html"><a href="B-2-supplementary-figures.html"><i class="fa fa-check"></i><b>B.2</b> Supplementary Figures</a></li>
</ul></li>
<li class="chapter" data-level="C" data-path="C-sup-position-effect.html"><a href="C-sup-position-effect.html"><i class="fa fa-check"></i><b>C</b> Supplemental Data: Position effects of rearrangements in disease genomes</a><ul>
<li class="chapter" data-level="C.1" data-path="C-1-supplemental-note.html"><a href="C-1-supplemental-note.html"><i class="fa fa-check"></i><b>C.1</b> Supplemental Note</a><ul>
<li class="chapter" data-level="C.1.1" data-path="C-1-supplemental-note.html"><a href="C-1-supplemental-note.html#case-reports"><i class="fa fa-check"></i><b>C.1.1</b> Case Reports</a></li>
<li class="chapter" data-level="C.1.2" data-path="C-1-supplemental-note.html"><a href="C-1-supplemental-note.html#nucleotide-level-nomenclature-for-dgap-karyotypes"><i class="fa fa-check"></i><b>C.1.2</b> Nucleotide Level Nomenclature for DGAP karyotypes</a></li>
</ul></li>
<li class="chapter" data-level="C.2" data-path="C-2-supplemental-figure.html"><a href="C-2-supplemental-figure.html"><i class="fa fa-check"></i><b>C.2</b> Supplemental Figure</a></li>
<li class="chapter" data-level="C.3" data-path="C-3-position-effect-sub-tab.html"><a href="C-3-position-effect-sub-tab.html"><i class="fa fa-check"></i><b>C.3</b> Supplemental Table Legends</a></li>
</ul></li>
<li class="chapter" data-level="D" data-path="D-loop-support.html"><a href="D-loop-support.html"><i class="fa fa-check"></i><b>D</b> Supplemental Information: Prediction of chromatin looping interactions</a><ul>
<li class="chapter" data-level="D.1" data-path="D-1-LoopPredSupTab.html"><a href="D-1-LoopPredSupTab.html"><i class="fa fa-check"></i><b>D.1</b> Supplementary Tables</a></li>
<li class="chapter" data-level="D.2" data-path="D-2-supplementary-figures-1.html"><a href="D-2-supplementary-figures-1.html"><i class="fa fa-check"></i><b>D.2</b> Supplementary Figures</a></li>
</ul></li>
<li class="chapter" data-level="E" data-path="E-contribution-to-individual-publications.html"><a href="E-contribution-to-individual-publications.html"><i class="fa fa-check"></i><b>E</b> Contribution to individual publications</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Build with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Genome folding in evolution and disease</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="discussion-1" class="section level2">
<h2><span class="header-section-number">4.4</span> Discussion</h2>
<p>Structural variation of the human genome, either inherited or arising by
<em>de novo</em> germline or somatic mutations, can give rise to different
phenotypes through several mechanisms. Chromosome rearrangements can
alter gene dosage, promote gene fusions, unmask recessive alleles, or
disrupt associations between genes and their regulatory elements. The
traditional clinical focus of studying genes disrupted by chromosome
rearrangements has shifted to also assess regions neighboring these
variants.<span class="citation">(Ordulu et al. <a href="#ref-Ordulu2016">2016</a>)</span> This search for positional effects has been particularly
important in the analysis of chromosome rearrangements associated with
different clinical conditions and disrupting non-annotated genomic
regions.<span class="citation">(Zhang and Wolynes <a href="#ref-Zhang2015">2015</a>; Spielmann and Mundlos <a href="#ref-Spielmann2016">2016</a>)</span></p>
<p>The study of chromatin conformation has been requisite in the analysis
of such non-coding rearrangements. DNA is organized in the
three-dimensional nucleus at varying hierarchical levels that are
important for the regulation of gene expression,<span class="citation">(Wit and Laat <a href="#ref-DeWit2012">2012</a>)</span> with primary roles
in embryonic development and disease.<span class="citation">(Bonev and Cavalli <a href="#ref-Bonev2016">2016</a>)</span> Several studies have analyzed
the impact of structural variants in disruption of the regulatory
chromatin environment leading to disease;<span class="citation">(Lupiáñez et al. <a href="#ref-Lupianez2015">2015</a>; Gröschel et al. <a href="#ref-Groschel2014">2014</a>; Visser et al. <a href="#ref-Visser2012">2012</a>; Roussos et al. <a href="#ref-Roussos2014">2014</a>; Giorgio et al. <a href="#ref-Giorgio2015">2015</a>; Ibn-Salem et al. <a href="#ref-Ibn-Salem2014">2014</a>)</span> these
studies have set the precedent for integrative analyses of disrupted
chromatin conformation to expedite functional annotations of non-coding
chromosome rearrangements.</p>
<p>We tested the possibility of utilizing chromatin contact information to
dissect chromosome rearrangements which disrupt non-coding chromosome
regions in clinical cases. We focused on 17 subjects from DGAP, 12 with
available clinical microarray information, with different rare
presentations and <em>de novo</em> non-coding BCAs classified as VUS. Of these,
15 corresponded to translocations and two were inversions. These cases
represent ~11% of the total number of sequenced DGAP cases, which makes
our predictions even more significant for future potential treatment or
management of subjects who would not otherwise obtain a clinical
diagnosis. Utilizing publicly available annotated genomic and regulatory
elements, chromatin conformation capture information, predicted
enhancer-promoter interactions, phenomatch scores, as well as
haploinsufficiency and triplosensitivity information for all genes
surrounding the BCA breakpoints at different window sizes (±3 and ±1 Mb
as well as BCA-containing TAD positions), we discovered 16 genes for 11
DGAP cases that are top-ranking position effect candidates for the
subjects’ clinical phenotypes (Table <a href="4-2-materials-and-methods.html#tab:position-effect-subjects">4.1</a>).</p>
<p>We observed that eight of the sequenced DGAP BCA breakpoints,
corresponding to six DGAP cases (DGAP017, 176, 249, 275, 288 and 322),
overlapped reported annotated and predicted enhancers and DHS sites.
Disruption of these regulatory elements could potentially cause improper
gene expression or repression through altered enhancer-promoter
interactions or interactions with other DHS-associated elements such as
insulators and locus control regions, among others. In fact, four of the
breakpoints that disrupt annotated DHS sites and enhancers have been
shown to establish chromatin contacts with our top position effect
candidate genes in the region in Hi-C data of H1-hESC cells at 40 Kb
resolution (<a href="C-3-position-effect-sub-tab.html#position-effect-sub-tab">Table S</a>18). For example, the DGAP275_B breakpoint is
involved in a chromatin interaction that puts it into physical proximity
with <em>POLE</em> and <em>ANKLE2,</em> DGAP288_B contacts <em>SOX9</em>, and DGAP176_B
interacts with <em>ACSL4</em>. Three additional breakpoints from DGAP111, 249
and 287 overlap CTCF binding sites. CTCF binding sites are enriched in
TAD boundaries,<span class="citation">(Dixon et al. <a href="#ref-Dixon2012">2012</a>)</span> and the elimination of these binding sites could
potentially induce gene expression or other functional changes through
alteration of the structural regulatory landscape of the region.<span class="citation">(Lupiáñez et al. <a href="#ref-Lupianez2015">2015</a>)</span></p>
<p>There are nine DGAP cases (DGAP113, 126, 138, 153, 163, 252, 315, 319
and 329), six with normal arrays and two with benign CNVs, for which no
overlap with genomic or other regulatory elements was detected. These
cases thus represent events in which position effects are most likely
caused by alteration of the underlying chromatin structure itself. This
hypothesis is supported by detection of a vast number of disrupted
chromatin contacts in four different cell lines (H1-hESC, IMR90,
GM06990, GM12878) at different Hi-C window resolutions, 32 breakpoints
included in H1-hESC TADs,<span class="citation">(Dixon et al. <a href="#ref-Dixon2012">2012</a>)</span> and the separation of 193 genes from one
and up to 91 of their predicted enhancers after the occurrence of the
BCAs (<a href="C-3-position-effect-sub-tab.html#position-effect-sub-tab">Table S</a>14). For example, <em>SOS1</em>, one of the most significant
candidates in explaining DGAP163’s global developmental delay,
dysmorphic/distinctive facies and hearing loss, as observed in Noonan
Syndrome 1 (NS1 [MIM: 163950]), is separated from its interaction with
88 predicted enhancers (Figure <a href="4-4-discussion-1.html#fig:position-effect-3">4.3</a>), and exhibited a decrease in
expression in DGAP163-derived LCLs. However, NS1 is caused by autosomal
dominant mutations in <em>SOS1</em>; we hypothesize that the reduced expression
of <em>SOS1</em> might affect the RAS/MAPK signaling pathway and generate
clinical features not completely overlapping those of NS1; however, this
possibility remains to be functionally tested and complimented with
analyses of genomic single nucleotide variants. A similar approach could
be explored for DGAP275, where we hypothesize that <em>POLE</em>, associated
with the facial dysmorphism, immunodeficiency, livedo, and short stature
syndrome (FILS [MIM: 615139]) in an autosomal recessive manner,<span class="citation">(Pachlopnik Schmid et al. <a href="#ref-PachlopnikSchmid2012">2012</a>)</span>
may contribute to the extreme short stature observed in this DGAP
subject; and <em>ZEB2</em>, etiologic for Mowat-Wilson syndrome (MOWS [MIM:
235730]) in an autosomal dominant manner (OMIM#235730), may
potentially explain the hypotonia and neurological features observed in
DGAP329 but not present all of the dysmorphic features or
medical/non-neurologic phenotype of MOWS. Overall, more candidate genes
will need to be analyzed rigorously to assess the validity of our
position effect predictions and the disruption of important chromatin
regulatory elements. Nonetheless, insight into the molecular pathway of
disorders may be forthcoming from our approach and of value in the
management of some individuals.</p>
<!-- ---------------------------------------------------------------- -->
<div class="figure" style="text-align: center"><span id="fig:position-effect-3"></span>
<img src="figures/position_effect/Figure3.png" alt="Disrupted enhancer-promoter DHS interactions predicted for SOS1 (gene position indicated by asterisk). The color graded rectangle represents the correlation values for the interactions as reported by ENCODE. The dashed line indicates the translocation breakpoint position in chromosome 2. Lilac colored rectangles represent genes, and pink rectangles show TAD positions annotated in H1-hESC." width="80%" />
<p class="caption">
Figure 4.3: <strong>Disrupted enhancer-promoter DHS interactions predicted for <em>SOS1</em> </strong> (gene position indicated by asterisk). The color graded rectangle represents the correlation values for the interactions as reported by ENCODE. The dashed line indicates the translocation breakpoint position in chromosome 2. Lilac colored rectangles represent genes, and pink rectangles show TAD positions annotated in H1-hESC.
</p>
</div>

<!-- ---------------------------------------------------------------- -->
<p>All predicted candidate genes have different lines of evidence
supporting their selection, starting with a significant phenomatch score
that correlates annotated gene phenotypes to those observed in the DGAP
cases. HI and triplosensitivity evidence, inclusion in TAD regions, as
well as HI scores build upon this selection, and can help laboratories
and clinicians focus in subsequent analyses on candidates of their
interest. As of now, the “top-ranking” candidates have the highest
number of evidence supporting their selection; however, there are also
102 second-tier candidates for the 17 analyzed DGAP cases within ±1 Mb
analysis windows which may well play a functional role. Presently, we
are unable to give “weights” to any of these selection criteria (<em>i.e</em>.,
a gene with a high phenomatch score and no evidence of HI is “more
significant” than a gene with a medium phenomatch score and evidence of
HI) mainly for two reasons: (i) we would need to collect more examples,
which might not be easy to find and require a tremendous curation
effort, and (ii) we need to understand the possibility, suggested by our
results, that more than one gene may be contributory in the clinical
presentation of the DGAP subjects, either acting simultaneously or
throughout development. Moreover, many of the candidates have recessive
inheritance modes, which make it necessary to assess the mutational
status of both alleles as well as additional sequence variants not
captured by our BCA breakpoint sequencing and the microarrays. Future
in-depth exome, DNA and RNA sequencing as well as Hi-C experiments will
provide a comprehensive view of the contribution of sequence variants,
disruption of chromatin contacts, and changes in gene expression in the
DGAP disease etiologies, such that guidelines might be developed as to
which candidates should be followed up first and further studied with
comprehensive functional validation using animal models and human cell
lines that reproduce the BCA breakpoints.</p>
<p>Overall our results suggest that the integration of phenomatch scores,
altered chromatin contacts, and other clinical gene annotations provide
valuable interpretation to many variants of uncertain significance
through long-range position effects. The correct prediction of 52 out of
57 known pathogenic genes in DGAP cases used as positive controls
supports such integration. Our computational analysis is rapid and can
provide additional information to benefit the clinical assessment of
both coding and non-coding genome variants. The latter is an important
step towards prediction of pathogenic consequences of non-coding
variantion observed in prenatal samples. For example, based on its
position and chromatin contact alterations, we correctly predicted the
involvement and decreased expression of <em>SOX9</em> in the cleft palate
Pierre-Robin sequence (PRBNS [MIM: 261800]) association in
DGAP288.<span class="citation">(Ordulu et al. <a href="#ref-Ordulu2016">2016</a>)</span></p>
<p>Lastly, we would like to note that predicting the pathogenic outcome of
disrupted chromatin contacts is not a straightforward endeavor: it has
been shown that a single gene promoter can be targeted by several
enhancers,<span class="citation">(Thurman et al. <a href="#ref-Thurman2012">2012</a>)</span> therefore compensating for the perturbed interactions by
the chromosome rearrangements. In addition, rearrangements can
reposition gene promoters and enhancers outside of their preferred
chromatin environments, leading to improper gene activation by enhancer
adoption.<span class="citation">(Lupiáñez et al. <a href="#ref-Lupianez2015">2015</a>)</span> Our method currently identifies instances in which known
and predicted enhancer/promoter interactions are disrupted by the
rearrangement breakpoints and thus lead to decreased candidate gene
expression. Enhancer adoption prediction will be incorporated once
mathematical models of TAD formation upon changes in genomic sequence
are refined and available to the greater scientific community.
Presently, our predictions are as good as the availability of pathogenic
gene annotations, chromatin conformation data, clinical phenotype
information, and the presence of similar rearrangements in databases
such as DECIPHER and dbVar. While the existence of other subjects with
related phenotypes to the DGAP cases does not prove the involvement of
neighboring genes in the etiology of these phenotypes, it is a step
forward towards prediction of pathogenic effects starting from a simple
computational analysis, pointing to a better phenotypic categorization
when clinically examining affected individuals. By making our position
effect prediction method available to the human genetics community, we
hope to study additional cases with complete phenotypic information and
be able to refine better the rules for the prediction of position
effects on gene expression and discover new mechanisms of pathogenicity.</p>
<div id="acknowledgements-1" class="section level3 unnumbered">
<h3>Acknowledgements</h3>
<p>We offer heartfelt gratitude to all DGAP research participants and their
families, and to countless genetic counselors, clinical geneticists,
cytogeneticists, and physicians for their ongoing support of our study
and for referrals to our project. This study was funded by the National
Institutes of Health (GM061354 to CCM and MET). The authors declare no
conflicts of interest.</p>
</div>
<div id="web-resources" class="section level3">
<h3><span class="header-section-number">4.4.1</span> Web Resources</h3>
<p>The scripts used in this study to predict position effects can be
downloaded from:
<a href="https://github.com/ibn-salem/position_effect"><em>https://github.com/ibn-salem/position_effect</em></a></p>
<p>OMIM, <a href="http://www.omim.org/"><em>http://www.omim.org</em></a></p>
<p>Ensembl GRCh37 archive,
<a href="http://grch37.ensembl.org/"><em>http://grch37.ensembl.org</em></a></p>
<p>Human lincRNAs catalog,
<a href="http://portals.broadinstitute.org/genome_bio/human_lincrnas"><em>http://portals.broadinstitute.org/genome_bio/human_lincrnas</em></a></p>
<p>Haploinsufficiency scores,
<a href="https://decipher.sanger.ac.uk/"><em>https://decipher.sanger.ac.uk</em></a></p>
<p>ClinGen GRCh37 data,
<a href="ftp://ftp.ncbi.nlm.nih.gov/pub/dbVar/clingen"><em>ftp://ftp.ncbi.nlm.nih.gov/pub/dbVar/clingen</em></a></p>
<p>University of California Santa Cruz Genome Browser,
<a href="https://genome.ucsc.edu/"><em>https://genome.ucsc.edu</em></a></p>
<p>Human Phenotype Ontology,
<a href="http://human-phenotype-ontology.github.io/"><em>http://human-phenotype-ontology.github.io</em></a></p>
<p>Harvard Biopolymers Facility,
<a href="https://genome.med.harvard.edu/"><em>https://genome.med.harvard.edu</em></a></p>
<p>dbVar Variation Viewer,
<a href="https://www.ncbi.nlm.nih.gov/variation/view"><em>https://www.ncbi.nlm.nih.gov/variation/view</em></a></p>
<p>3D Genome Browser,
<a href="http://promoter.bx.psu.edu/hi-c"><em>http://promoter.bx.psu.edu/hi-c</em></a></p>
<p>ENCODE,
<a href="https://www.encodeproject.org/"><em>https://www.encodeproject.org</em></a></p>
<p>WashU EpiGenome Browser,
<a href="http://epigenomegateway.wustl.edu/"><em>http://epigenomegateway.wustl.edu/</em></a></p>
<p>GTEx portal,
<a href="https://www.gtexportal.org/home"><em>https://www.gtexportal.org/home</em></a></p>

</div>
</div>
<!-- </div> -->
<h3>References</h3>
<div id="refs" class="references">
<div id="ref-Ordulu2016">
<p>Ordulu Z, Kammin T, Brand H, Pillalamarri V, Redin CE, Collins RL, Blumenthal I, Hanscom C, Pereira S, Crandall BF, et al. 2016. Structural chromosomal rearrangements require nucleotide-level resolution : Lessons from next-generation sequencing in prenatal diagnosis. <em>The American Journal of Human Genetics</em> 1–19.</p>
</div>
<div id="ref-Zhang2015">
<p>Zhang B, Wolynes PG. 2015. Topology, structures, and energy landscapes of human chromosomes. <em>Proceedings of the National Academy of Sciences</em> <strong>112</strong>: 201506257.</p>
</div>
<div id="ref-Spielmann2016">
<p>Spielmann M, Mundlos S. 2016. Looking beyond the genes: The role of non-coding variants in human disease. <em>Human Molecular Genetics</em> ddw205.</p>
</div>
<div id="ref-DeWit2012">
<p>Wit E de, Laat W de. 2012. A decade of 3C technologies: Insights into nuclear organization. <em>Genes &amp; development</em> <strong>26</strong>: 11–24.</p>
</div>
<div id="ref-Bonev2016">
<p>Bonev B, Cavalli G. 2016. Organization and function of the 3D genome. <em>Nature Reviews Genetics</em> <strong>17</strong>: 661–678.</p>
</div>
<div id="ref-Lupianez2015">
<p>Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, Horn D, Kayserili H, Opitz JM, Laxova R, et al. 2015. Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions. <em>Cell</em> <strong>161</strong>: 1012–1025.</p>
</div>
<div id="ref-Groschel2014">
<p>Gröschel S, Sanders MA, Hoogenboezem R, Wit E de, Bouwman BAM, Erpelinck C, Velden VHJ van der, Havermans M, Avellino R, Lom K van, et al. 2014. A single oncogenic enhancer rearrangement causes concomitant evi1 and gata2 deregulation in leukemia. <em>Cell</em> <strong>157</strong>: 369–381.</p>
</div>
<div id="ref-Visser2012">
<p>Visser M, Kayser M, Palstra R-J. 2012. HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the oca2 promoter. <em>Genome research</em> <strong>22</strong>: 446–55.</p>
</div>
<div id="ref-Roussos2014">
<p>Roussos P, Mitchell AC, Voloudakis G, Fullard JF, Pothula VM, Tsang J, Stahl EA, Georgakopoulos A, Ruderfer DM, Charney A, et al. 2014. A role for noncoding variation in schizophrenia. <em>Cell reports</em> <strong>9</strong>: 1417–29.</p>
</div>
<div id="ref-Giorgio2015">
<p>Giorgio E, Robyr D, Spielmann M, Ferrero E, Di Gregorio E, Imperiale D, Vaula G, Stamoulis G, Santoni F, Atzori C, et al. 2015. A large genomic deletion leads to enhancer adoption by the lamin b1 gene: A second path to autosomal dominant adult-onset demyelinating leukodystrophy (adld). <em>Human Molecular Genetics</em> <strong>24</strong>: 3143–3154.</p>
</div>
<div id="ref-Ibn-Salem2014">
<p>Ibn-Salem J, Köhler S, Love MI, Chung H-R, Huang N, Hurles ME, Haendel M, Washington NL, Smedley D, Mungall CJ, et al. 2014. Deletions of chromosomal regulatory boundaries are associated with congenital disease. <em>Genome Biology</em> <strong>15</strong>: 423.</p>
</div>
<div id="ref-Dixon2012">
<p>Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B. 2012. Topological domains in mammalian genomes identified by analysis of chromatin interactions. <em>Nature</em> <strong>485</strong>: 376–380.</p>
</div>
<div id="ref-PachlopnikSchmid2012">
<p>Pachlopnik Schmid J, Lemoine R, Nehme N, Cormier-Daire V, Revy P, Debeurme F, Debré M, Nitschke P, Bole-Feysot C, Legeai-Mallet L, et al. 2012. Polymerase <span class="math inline">\(\epsilon\)</span>1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (&quot;fils syndrome&quot;). <em>The Journal of experimental medicine</em> <strong>209</strong>: 2323–30.</p>
</div>
<div id="ref-Thurman2012">
<p>Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. 2012. The accessible chromatin landscape of the human genome. <em>Nature</em> <strong>489</strong>: 75–82.</p>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="4-3-results-2.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="5-loop.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": true,
"facebook": false,
"twitter": true,
"google": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/ibn-salem/thesis/edit/master/04-position_effect.Rmd",
"text": "Edit"
},
"download": ["thesis.pdf", "thesis.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:" && /^https?:/.test(src))
      src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
